Facebook Linkedin Twitter
Inside Precision Medicine Can We Still Contain, and Possibly Eliminate, COVID-19? Yes, and Here Is How

Remdesivir

Illustration of several SARS-CoV-2 virus particles in blue on a red background
Coronavirus

Can We Still Contain, and Possibly Eliminate, COVID-19? Yes, and Here Is How

Kathy Vuksanaj -
0
Electron microscopy virus visualization. COVID-19
Coronavirus

Insights on Proteolysis May Offer New Treatments for COVID-19

Malorye Branca -
0
remdesivir covid-19 liquid medication background
Coronavirus

COVID-19 Antiviral Treatment Remdesivir’s Effectiveness Boosted 10X by Hepatitis C Drug

Kevin Mayer -
0
RNA strands inside corona virus
Coronavirus

New SARS-CoV-2 Mutations Emerge in Patient with Cancer and COVID-19

Malorye Branca -
0
Image showing the SARS-CoV-2 virus being attacked by a COVID-19 antiviral drug such as molnupiravir
Coronavirus

NIH Launches COVID-19 Trial Testing Remdesivir Plus Baricitinib or Dexamethasone

Helen Albert -
0
FDA’s First COVID-19 Drug Approval Goes to Gilead’s Remdesivir
Coronavirus

FDA’s First COVID-19 Drug Approval Goes to Gilead’s Remdesivir

Alex Philippidis -
0
Pack of Remdesivir pills
Coronavirus

WHO: Remdesivir Has “Little or No Effect” as Hospital COVID-19 Treatment

Alex Philippidis -
0
NIH Launches COVID-19 Clinical Trial of Immune Modulators
Coronavirus

NIH Launches COVID-19 Clinical Trial of Immune Modulators

Chris Anderson -
0
Latest COVID-19 Phase III Trial Pause: Eli Lilly’s Antibody Therapy Candidate
News & Features

Latest COVID-19 Phase III Trial Pause: Eli Lilly’s Antibody Therapy Candidate

Alex Philippidis -
0
remdesivir covid-19 liquid medication background
Coronavirus

NIAID COVID-19 Trial to Compare Results of Antibody Therapies in Combination with Remdesivir

Alex Philippidis -
0
12Page 1 of 2

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine